An overview of 5-HT 3 receptor antagonists as a treatment option for irritable bowel syndrome with diarrhea.
Karolina MereczMikołaj HirsaOlga BiniszewskaJakub FichnaAleksandra TarasiukPublished in: Expert opinion on pharmacotherapy (2023)
receptor agonism appears to be an appealing alternative to a silent antagonist for the treatment of IBS-D.